Business Description
Establishment Labs Holdings Inc
ISIN : VGG312491084
Description
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.2 | |||||
| Equity-to-Asset | 0.12 | |||||
| Debt-to-Equity | 6.06 | |||||
| Debt-to-EBITDA | -3.88 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.6 | |||||
| Beneish M-Score | -1.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21.1 | |||||
| 3-Year EBITDA Growth Rate | -28.7 | |||||
| 3-Year EPS without NRI Growth Rate | -22.1 | |||||
| 3-Year FCF Growth Rate | -84.4 | |||||
| 3-Year Book Growth Rate | -39.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 55.66 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 24.26 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.32 | |||||
| 9-Day RSI | 55.77 | |||||
| 14-Day RSI | 55.23 | |||||
| 12-1 Month Momentum % | 12.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.62 | |||||
| Quick Ratio | 2.29 | |||||
| Cash Ratio | 0.79 | |||||
| Days Inventory | 479.67 | |||||
| Days Sales Outstanding | 133.38 | |||||
| Days Payable | 224.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.5 | |||||
| Shareholder Yield % | -5.39 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.08 | |||||
| Operating Margin % | -34.91 | |||||
| Net Margin % | -46.13 | |||||
| FCF Margin % | -57.72 | |||||
| ROE % | -192.37 | |||||
| ROA % | -25.06 | |||||
| ROIC % | -28.37 | |||||
| 3-Year ROIIC % | -30.29 | |||||
| ROC (Joel Greenblatt) % | -31.41 | |||||
| ROCE % | -22.62 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 8.17 | |||||
| PB Ratio | 38.76 | |||||
| Price-to-Tangible-Book | 56.49 | |||||
| EV-to-EBIT | -27.17 | |||||
| EV-to-Forward-EBIT | -72.8 | |||||
| EV-to-EBITDA | -27.91 | |||||
| EV-to-Forward-EBITDA | -91.06 | |||||
| EV-to-Revenue | 9.32 | |||||
| EV-to-Forward-Revenue | 10.16 | |||||
| EV-to-FCF | -16.36 | |||||
| Earnings Yield (Greenblatt) % | -3.68 | |||||
| FCF Yield % | -6.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Establishment Labs Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 140.365 | ||
| EPS (TTM) (€) | -2.366 | ||
| Beta | 1.47 | ||
| Volatility % | 28.66 | ||
| 14-Day RSI | 55.23 | ||
| 14-Day ATR (€) | 1.980979 | ||
| 20-Day SMA (€) | 39.8 | ||
| 12-1 Month Momentum % | 12.58 | ||
| 52-Week Range (€) | 27.8 - 45.4 | ||
| Shares Outstanding (Mil) | 27.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Establishment Labs Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Establishment Labs Holdings Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Establishment Labs Holdings Inc Frequently Asked Questions
What is Establishment Labs Holdings Inc(FRA:3E0)'s stock price today?
The current price of FRA:3E0 is €41.80. The 52 week high of FRA:3E0 is €45.40 and 52 week low is €27.80.
When is next earnings date of Establishment Labs Holdings Inc(FRA:3E0)?
The next earnings date of Establishment Labs Holdings Inc(FRA:3E0) is 2025-02-28 Est..
Does Establishment Labs Holdings Inc(FRA:3E0) pay dividends? If so, how much?
Establishment Labs Holdings Inc(FRA:3E0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers